对SNARE综合体回收机器的机械洞察力
Minglei Zhao1, Shenping Wu2, Qiangjun Zhou1
1Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA.
Nature
|January 13, 2015
概括
研究人员可视化了NSF/SNAP/SNARE复合体,揭示了NSF ATPase如何分解SNARE复合体进行膜融合. 在NSF和SNAP相互作用中的结构变化表明了回收SNARE蛋白的机制.
科学领域:
- 分子生物学分子生物学
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- SNARE蛋白调解了膜融合,这是真核细胞中的一个关键过程.
- 与SNAP一起的NSF ATPase将SNARE复合体分解,使其能够回收利用.
研究的目的:
- 确定与ATP和ADP结合的NSF的近原子结构.
- 为了阐明NSF/SNAP/SNARE (20S) 超级复杂的结构.
主要方法:
- 使用单粒子电子冷显微镜 (cryo-EM) 进行了研究.
- 在没有对称性约束的情况下获得了近原子到亚纳米分辨率结构.
主要成果:
- 与ATP和ADP结合的NSF之间的形状差异表明产生力.
- 20S超级复合体显示的对称性被打破,从NSF的六倍对称性过渡到SNARE的伪四倍对称性.
- 通过对立的扭曲,SNAP与SNARE相互作用,表明一个解机制.
结论:
- 该研究提供了对SNARE复合物的NSF介导拆卸的结构性见解.
- 接口上的静电图案表明NSF/SNAP对各种SNARE复合体的广泛作用.
- 这项工作揭示了驱动膜融合调节的分子机械.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Small interfering RNAs (siRNA)
4.3K
No description available
4.3K
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors
539
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539